UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004562
Receipt number R000005451
Scientific Title Reduced fluence photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor antibody for age-related macular degeneration.
Date of disclosure of the study information 2010/11/15
Last modified on 2016/05/23 13:34:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Reduced fluence photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor antibody for age-related macular degeneration.

Acronym

RFPDT combined with anti-VEGF antibody for AMD.

Scientific Title

Reduced fluence photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor antibody for age-related macular degeneration.

Scientific Title:Acronym

RFPDT combined with anti-VEGF antibody for AMD.

Region

Japan


Condition

Condition

Age-related macular degeneration

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess outcome for patients with AMD treated with RFPDT combined with anti-VEGF.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

vision acuity, disapearment of neovascularization.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

RFPDT
anti-VEGFantibody

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

120 years-old >

Gender

Male and Female

Key inclusion criteria

Finding choroidal vascular abnormalities with AMD, and vision loss.

Key exclusion criteria

the patient without exudative changes in fundus.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidetoshi Yamashita

Organization

Yamagata University faculty of Medicine

Division name

Department of Ophthalmology

Zip code


Address

2-2-2 Iidanishi Yamagata

TEL

023-628-5374

Email

hyama-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shion Hayashi

Organization

Yamagata University faculty of Medicine

Division name

Department of Ophthalmology

Zip code


Address

2-2-2 iidanishi Yamagata

TEL

+81-23-628-5374

Homepage URL


Email

shion_haneda055@hotmail.com


Sponsor or person

Institute

Yamagata University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

Yamagata University Faculty of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 11 Month 15 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2009 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 04 Month 01 Day

Last follow-up date

2011 Year 11 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 11 Month 15 Day

Last modified on

2016 Year 05 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005451


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name